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ABSTRACT 
Objectives To compare the knowledge and the willingness of emergency physicians and gynaecologists 
caring for women in Italian emergency departments (EDs) to prescribe levonorgestrel-only emergency 
contraceptive pills (LNG-EC pills). 
Methods A cross-sectional survey was conducted in 2009; anonymous postal questionnaires were 
mailed to the medical staff working at the 30 EDs located in Piedmont (Italy). 
Results Emergency physicians and gynaecologists have similar knowledge of the pharmacokinetics and 
pharmacodynamics of LNG-EC pills, but do not feel at ease in prescribing these and consider the 
prescription of LNG-EC pills an inappropriate activity for ED staff. 
Conclusions In Italy, unlike in most other European countries, LNG-EC pills are still prescription drugs. 
Thus it may be useful to further investigate the reasons why Italian ED medical staff do not feel the 
prescription of LNG-EC pills should be within their remit and whether women can successfully obtain 
the prescription from physicians working in other services that can be accessed around the clock. 
Keywords:Emergency contraception,Emergency department,Gynaecologist,Emergency physician 
 
INTRODUCTION 
Emergency contraception (EC) refers to the use of drugs or intrauterine devices to prevent unwanted 
pregnancy after unprotected sexual intercourse. Systematic reviews have shown that EC pills are safe 
and associated with mild side effects such as nausea, vomiting, headache, dizziness, fatigue, breast 
tenderness, diarrhoea, and spotting or bleeding. Contrary to initial observations, EC pills significantly 
increase neither the risk of ectopic pregnancy1 nor that of harm to the developing embryo2. 
In Italy levonorgestrel-only pills (LNG-EC pills) have been registered for EC since 2001. Initially 
marketed as two tablets of 750 μg, since 2011 they have only been available as one tablet of 1500 μg, 
as recommended by the World Health Organisation (WHO)3. According to a recent Cochrane 
systematic review, there are no significant differences in drug efficacy or in the incidence of side 
effects whether LNG-EC pills are administered in a single dose or according to a 12-hour split-dose 
regimen1. 
The efficacy of LNG-EC pills had been demonstrated up to 72 hours after unprotected coitus, but there 
was uncertainty about its effectiveness thereafter and whether or not its efficacy decreases with time 
since intercourse. A recent study combining data from four WHO randomised controlled trials 
concluded that it is still not established whether LNG-EC pills can protect against unintended 
pregnancy when administered on day five. At the same time it suggested that LNG-EC pills are 
effective up to 96 hours after unprotected sexual intercourse without evidence of a reduction in their 
efficacy up to this time interval. Nonetheless the authors suggested that LNG-EC pills should be 
administered as soon as possible after unprotected intercourse1,4,5. 
It has been observed that women mostly ask for EC promptly, up to 24 hours after unprotected coitus, 
and that requests present an irregular trend, with peaks occurring during summer months (June to 
September), holidays (e.g., New Year's Day) and weekends (from Saturday to Monday)6–9. 
These data give a plausible explanation why emergency departments (EDs) could be an important 
venue for EC prescription in countries where EC pills are only available with a medical prescription; 
this applies to Italy where they can be prescribed by any physician. In practice, however, during 
weekends or holidays the drug can be obtained only from physicians working at an ED or by 
physicians on out-of-hours duty – physicians who replace general practitioners in their activities during 
the nights, weekends and holidays. After having received a medical prescription, women have to go to 
a pharmacy that is also open out of hours, and buy the drug. In this context it is very important for 
women to find, as soon as possible, a physician working out of hours or an emergency physician 
willing to issue the prescription. 
Numerous studies investigating ED medical staff's willingness to prescribe EC have shown that women 
find it difficult to obtain EC pills for a variety of reasons. Some investigators have cited the main 
reason for prescription refusal to be the fact that ED staff do not view unprotected sexual intercourse as 
a medical emergency or the provision of care needed in such situation as an appropriate activity for the 
ED10,11. To date, only a few studies have analysed medical staff's knowledge about the mechanism of 
action, efficacy and mode of proper administration of LNG-EC pills12. 
For that reason we first carried out a survey to determine the frequency of requests of LNG-EC pills, 
the features of women asking for the drug, and the responses given by emergency physicians working 
at EDs in Piedmont13. We found that in the physicians’ opinion the vast majority of requests came from 
Italian nationals (97%) ranging in age from 18–30 years (76%), single and not cohabiting with a 
partner (60%), and nulliparous (64%). Women mostly had not used LNG-EC pills before and the most 
common reasons for the request were condom breakage or slippage. Just over half the physicians stated 
that LNG-EC pills prescription was not an appropriate part of care provided at an ED, and most of 
them stated they felt uneasy about prescribing the drug. The vast majority of respondents stated they 
were willing to prescribe the drug if requested to do so, even if some of them believed that a physician 
could affirm his right to conscientious objection13. 
This second study started from the observation that, in Piedmont, women seeking EC at an ED can be 
seen by an emergency physician or by a gynaecologist. The specialty of the physician who takes care of 
women depends on organisational choices independently decided in each hospital. 
The aim of the present study was to compare opinions and behaviours reported in relation to LNG-EC 
pills prescription by gynaecologists to the ones expressed in our previous study by emergency 
physicians, and to compare the degree of knowledge about LNG EC pills’ pharmacokinetics and 
pharmacodynamics between the two groups of professionals. 
 
METHODS 
A first cross-sectional survey was conducted in 2009 among 152 emergency physicians working in the 
30 EDs in Piedmont (Italy). Twenty-four of these were first level EDs – EDs set in hospitals where a 
radiology unit, a laboratory and a blood transfusion service are accessible around the clock – while the 
six others were second level EDs – EDs set in hospitals which also have more specialised wards (e.g., 
Neurosurgery, Cardiac-, Thoracic- and Vascular Surgery). The first survey was followed a few months 
later by a second one, extended to 197 gynaecologists who may care for women requesting LNG-EC 
pills in the same EDs in Piedmont. 
Postal questionnaires were mailed to each physician together with stamped, addressed envelopes in 
order for the completed questionnaires to be returned anonymously. The questionnaire had been 
validated before the first survey. The instrument design and corresponding references have been 
described elsewhere13. Here we analyse the answers given to 17 of the original 24 questions, which we 
consider most relevant to make a comparison between the two groups of professionals. The questions 
refer to six areas: (1) professional profile; (2) number and frequency distribution of LNG-EC pills 
prescription requests; (3) the physician's knowledge about LNG-EC pills pharmacokinetics; (4) the 
physician's knowledge about LNG-EC pills pharmacodynamics; (5) the physician's behaviour/opinions; 
and (6) the physician's role in the ED. 
Approval was not sought from an ethics committee, because this is not required by law for anonymous 
postal questionnaire surveys in Italy. The questionnaires were accompanied by an information letter 
explaining the purpose of the study, the staff involved and a reminder that the completion of the 
questionnaires had to be done anonymously and that data obtained would be treated only in aggregate 
form. 
Statistical analysis 
Descriptive data are shown as absolute and relative frequencies of the different modalities for 
categorical data and as means ± standard deviation (SD) for continuous variables. Student's t- test was 
applied to quantitative variables to compare the two study groups. 
Univariate analysis (χ2 test or Fisher's exact test) was performed to verify if there was a statistically 
significant difference between the two groups in their knowledge about LNG-EC pills 
pharmacokinetics and pharmacodynamics, and in their personal behaviours and opinions. 
Multivariate analysis was carried out using a logistic regression model to assess differences between 
the professional profiles of the two groups. The accuracy of response to the items was taken as the 
dependent variable; specialties (gynaecologist vs. emergency physician), gender, age, ED level (First vs. 
Second level ED), geographic location of the ED (regional or provincial capital vs. small town), 
requests for LNG-EC pills received in the previous year (yes vs. no) were considered as independent 
variables. For all tests the significance level was set at α =0.05. 
All analyses were performed using Stata software version 9.2. 
 
RESULTS  
Responses were returned by 53 gynaecologists (27%) and 75 emergency physicians (49%) working at 
Piedmont EDs (Table 1). There was no statistically significant difference between the two groups in 
relation to sex, age, or ED level. A significantly greater proportion of gynaecologists who responded, 
worked at an ED located in a regional or provincial capital whereas 51% of emergency physicians who 
responded, worked at an ED located in a small town. 
Emergency physicians were significantly more likely to have received a request for EC within the last 
year than were gynaecologists (Table 2). The absolute numbers of respondents varied, because while 
all the physicians who stated they had received some requests for EC prescription in the past year 
responded to the questions asked through the questionnaire – including the ones regarding their 
knowledge and their feelings – only some of those who stated they had received no requests responded 
to all the questions. Most physicians had not observed a seasonal trend in the requests, but they stated 
that they were more frequent at weekends (Table 2). Two thirds of emergency physicians reported that 
women had been refused a prescription by another service (Table 3). 
ust over half of the respondents in either group considered LNG-EC pills prescription to be an 
inappropriate service for an ED. Just under half stated they felt uneasy with EC prescription. 
Nonetheless, virtually three quarters mentioned they were willing to prescribe the drug and to give 
women specific information on regular contraception when asked to prescribe LNG-EC pills (Table 3). 
Whereas more than half believed that LNG-EC pills should always be prescribed when requested, a 
quarter believed that it is possible to exercise a right to conscientious objection under the Italian Code 
of Medical Ethics. As many as 21% of the gynaecologists and 14% of the emergency physicians 
thought that it is possible to exercise a right to conscientious objection under Italian legislation 
regulating voluntary abortion (Table 3). 
There was no statistically significant difference between the two groups with regard to their knowledge 
of pharmacokinetics (Table 4). 
Most physicians in both groups stated that LNG-EC pills can be prescribed in more than one 
circumstance (Table 4). Very few chose only rape as a condition in which the drug should be 
prescribed, and only a small percentage in each group indicated the time criterion suggested by WHO – 
a history of unprotected sexual intercourse in the 120 hours preceding the request – contrary to our 
expectation. 
There were no statistically significant differences between the two groups with regard to their 
knowledge of pharmacodynamics of LNG-EC pills, except for the manner of taking the drug (Table 5). 
While gynaecologists seem to think it makes no difference whether the pills are taken at once or at an 
interval of 12 hours of each other, more than a half of emergency physicians stated that both pills 
should be taken in a single dose (p=0.003). There was a statistically significant difference between the 
answers given by the two groups at univariate analysis, but this difference was not confirmed at 
multivariate analysis, after adjusting for gender, age, ED level, geographic location of the ED and 
requests for LNG-EC pills received (yes vs. no) in the previous year (p=0.138). 
With regard to the knowledge of the mechanism of action of LNG-EC pills, the majority of respondents 
stated that they act through a complex mechanism of action involving inhibition of ovulation and 
fertilisation, alteration in tubal ciliary motility and sperm motility, and inhibition of implantation of the 
embryo; only 4% of gynaecologists correctly stated that the pill acts by inhibiting ovulation compared 
to 18% of emergency physicians. There was a statistically significant difference between the answers 
given by the two groups at univariate analysis, but this difference was not confirmed by multivariate 
analysis (p=0.093). 
Both groups agreed with the statements that LNG-EC pills usually do not cause important side effects 
but can cause nausea, vomiting and headache, and that laboratory examinations before prescription are 
unnecessary. 
Finally we also asked the participants what consequences may result from the use of LNG-EC pills. It 
was possible to give more than one answer. The most cited consequences were ‘a decrease in voluntary 
abortions’ and ‘a decrease in unwanted pregnancies’, followed by ‘an increased risk of no longer using 
regular contraception’, ‘an increase in risky sexual behaviour and sexually transmitted infections 
(STIs)’, and ‘a greater chance of empowering women in relation to their reproductive health’. 
 
DISCUSSION 
This survey shows that emergency physicians and gynaecologists have similar knowledge of the 
pharmacokinetics and pharmacodynamics of LNG-EC pills. Unfortunately, the study has revealed that 
a significant proportion of them did not have a full knowledge of these aspects of the drug. In particular, 
many of them ascribed the pharmacological action of the pills to a multiple and complex mechanism of 
action, rather than only to the delay or inhibition of ovulation. A small but relevant number of them 
also stated that LNG-EC pills are abortifacients and that they act similarly to mifepristone. These data 
are a matter of concern, even if they come from a small sample, and further thought must be given to 
this problem. Because LNG-EC pills inhibit ovulation by a different mechanism than that 
characterising combined hormonal contraceptives, it is possible that the claim that the LNG-EC pills 
act by inhibiting ovulation like other contraceptives has not been considered a fully correct answer by 
some clinicians, causing some misunderstanding. Nonetheless the answers chosen by most of these 
professionals are inconsistent with the literature16–19. Their responses may be partly explained by an 
incomplete update, but confounding messages regarding the mechanism of action of LNG-EC pills 
released for years in Italy may also be a factor. The Italian Ministerial Decree authorising the sale of 
LNG-EC pills and the drugs’ leaflets still state that LNG-EC pills can inhibit not only ovulation, but 
also embryo implantation. For that reason it has been stated for many years that LNG-EC pills had to 
be considered as abortifacients from a moral point of view20: a statement recently renewed by the 
Italian National Committee on Bioethics despite clear evidence to the contrary. 
We also found that some professionals considered a pregnancy test or blood coagulation tests to be 
necessary before the prescription of LNG-EC pills. This factor was independent of specialty and 
suggested that some professionals still overestimate the risk of side effects, and are overcautious in 
prescribing the drug. 
It is also relevant that, even if most responding emergency physicians and gynaecologists were willing 
to prescribe the drug, many of them felt ill at ease about doing so and considered it an inappropriate 
activity for ED staff. This observation is in line with other previous studies10,13,14 and, in our opinion, 
several factors might be involved, such as the particular professional's moral views, and organisational 
aspects. Physicians may feel not at ease in prescribing the drug if they judge this to be immoral, but 
they may also experience discomfort, because they consider that going to an ED and asking for a 
prescription of EC pills is an inappropriate use of emergency resources and service. Indeed the 
prescription of EC pills does not usually need medical or laboratory examinations, and it may be more 
appropriately addressed by general practitioners and physicians of out-of-hours duty. Both these 
aspects could explain the findings of former inquiries that highlighted that doctors were less likely to 
prescribe EC pills to women asking for them after a voluntary unprotected intercourse than to victims 
of rape who need urgent medical assistance11,12,15. Unfortunately our study did not focus on this aspect 
and it did not allow us to further investigate the reasons for the feelings and opinions given by 
professionals. 
Strengths and limitations of the study 
This study has three main strengths. First of all it was conducted at Italian EDs, for which little 
information is on record. Second, it was conducted in a health system where women who go to an ED 
and ask for a prescription of LNG-EC pills can be seen either by emergency physicians or by 
gynaecologists, so that we could make a comparison between these two groups of professionals. Third, 
it examined the level of knowledge of the pharmacokinetic and pharmacodynamic characteristics of 
LNG-EC pills by ED medical staff, an aspect that other studies on record did not take into 
consideration11,12,14,15. 
At the same time, it has some important limitations. It was conducted through postal questionnaires and 
the response rate was low. This fact may have introduced a selection bias due to a possible higher 
response rate from physicians more sensitive to the issue addressed. Therefore the level of knowledge 
of physicians and their willingness to prescribe the drug could be overestimated. This is a particularly 
important aspect with regard to the answers provided by gynaecologists. Second, the reported data on 
the number and frequency distribution of the requests of LNG-EC pills can be in part subjective. Third, 
it was not possible to investigate in depth some important aspects, such as the reasons why many 
professionals feel uncomfortable in prescribing the drug and consider it an inappropriate activity for 
EDs’ medical staff. 
Relevance of the findings: Implications for clinicians and policymakers 
Our research shows that emergency physicians and gynaecologists have similar knowledge of LNG-EC 
pills and that they are willing to prescribe the drug. The data we gathered suggest that both emergency 
physicians and gynaecologists are familiar with LNG-EC pills and that women may be safely referred 
to either group to obtain a prescription for this product. Nonetheless the findings must be interpreted 
with caution due to the small sample size. Our study also supported the evidence that several 
physicians working at EDs do not consider the prescription of this drug an appropriate activity for ED 
staff, and that they feel uncomfortable in prescribing it. 
Future research 
The latter finding is relevant and it could be useful to further investigate in detail the reasons for those 
feelings through in-depth interviews that can better explore motivations and points of view. 
At the same time it could also be useful to investigate whether women ask for prescription of LNG-EC 
pills from other services – such as physicians on out-of-hours duty or general practitioners – and if the 
latter are willing to issue the prescription. Even if in most European countries EC pills are available in 
pharmacies without medical prescription, they still can only be accessed by medical prescription in 
Italy. Moreover, unlike in France or in Sweden, in Italy EC pills cannot be issued by nurses or 
midwives, but only by physicians. 
In this context, the recent authorisation of ulipristal acetate as an EC could only in part change the 
attitude of Italian ED medical staff towards EC pills prescription. The availability of ulipristal – which 
can be taken up to five days after unprotected intercourse – can theoretically increase the chance of 
women receiving EC on time, even when sexual intercourse takes place during the weekend or holidays. 
However, in Italy, ulipristal EC pills not only require a medical prescription but also a negative 
pregnancy test prior to prescription. Thus women may obtain the prescription easily only from services 
which usually provide such a test, like an ED, a gynaecologist or a family planning clinic. Ulipristal 
acetate might be more difficult to obtain from a general practitioner or a physician on out-of-hours duty, 
as they do not usually provide pregnancy tests in their surgeries. 
 
CONCLUSION 
This is the first study which compares the knowledge and feelings of emergency physicians and 
gynaecologists regarding the prescription of LNG-EC pills. It shows that the level of knowledge of the 
pharmacology of the drug is similar in the two groups of professionals, even if some relevant gaps still 
exist, in particular regarding the mechanisms of action of these pills. In line with previous observations 
it also shows that many emergency physicians and gynaecologists consider the prescription of LNG-EC 
pills an inappropriate activity for ED staff and that they do not feel at ease in performing it. 
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 Table 1 Personal data of responding physicians. 
 Gynaecologists (n = 
53 ) 
Emergency physicians (n 
= 75 ) 
p-
value 
Sex (Male, %) 24 (46%) 42 (57%) 0.241 
Age (mean ± SD*) 42.6 ± 9.6 44.2 ± 7.4 0.311 
Emergency Department, level (second level, %) 30 (63%) 38 (54%) 0.375 
Emergency Department, geographical location (regional or 
provincial capital, %) 
40 (82%) 36 (49%) <0.001 
*SD, standard deviation. 
 
Table 2 Number and frequency distribution of prescription of levonorgestrel-only (LNG-EC) 
pills 
Number and frequency distribution of LNG-
EC prescription requests 
Gynaecologists (n = 
53) 
Emergency physicians 
(n = 75) 
p-
value 
How many requests for LNG-EC pills did you receive in the past year? 
0 36 (68%) 2 (3%) 0.000 
1–20 12 (23%) 51 (68%)   
21–40 4 (8%) 18 (24%)   
41–80 1 (2%) 4 (5%)   
> 80 0 (0%) 0 (0%)   
Total of respondents 53 (100%)* 75 (100%)   
In which period of the year were requests most frequent? 
Spring 0 (0%) 6 (8%) 0.217 
Summer 3 (11%) 10 (13%)   
Autumn 0 (0%) 2 (3%)   
Winter 0 (0%) 5 (7%)   
None of the above 24 (89%) 52 (69%)   
Total of respondents 27 (100%) 75 (100%)   
On which days were requests most frequent? (more than one answer was possible) 
Monday 0 (0%) 2 (3%) 0.654 
Tuesday to Friday 0 (0%) 2 (3%)   
Weekend 21 (96%) 55 (82%)   
Weekend and Monday 0 (0%) 1 (2%)   
Tuesday to Friday and Weekend 0 (0%) 4 (6%)   
All the week 1 (5%) 3 (5%)   
Total of respondents 22 (100%)* 67 (100%)*   
*The sum of the reported percentages may not amount to 100% because of the rounding off. 
 
 Table 3 Physician's behaviour/attitudes and physician's role at the Emergency Department. 
Physician's behaviour/attitudes* Gynaecologists (n 
= 53) 
Emergency 




Do you think that dispensing LNG-EC pills is appropriate for an Emergency Department? 
Yes 24 (47%) 36 (48%)   
No 27 (53%) 39 (52%) 0.917 
Total of respondents 51 (100%) 75 (100%)   
How comfortable do you feel about dispensing LNG-EC pills? 
Very uncomfortable 8 (17%) 16 (22%)   
Slightly uncomfortable 12 (25%) 18 (24%)   
Fairly comfortable 10 (21%) 20 (27%) 0.750 
Very comfortable 3 (6%) 4 (5%)   
Absolutely comfortable 15 (31%) 16 (22%)   
Total of respondents 48 (100%) 74 (100%)   
When asked to give a LNG-EC pill: 
I prescribe it and give information about regular contraception 32 (73%) 53 (74%)   
I prescribe it but do not give information about regular 
contraception 
2 (5%) 14 (19%)   
I refuse to give it and refer the woman to a gynaecologist instead 9 (21%) 3 (4%) 0.000 
I refuse to give it and inform the woman that I have a conscientious 
objection 
1 (2%) 2 (3%)   
Total of respondents 44 (100%)** 72 (100%)   
Physician's role at the Emergency Department*       
When asked to give a LNG-EC pill: 
It should always be provided 26 (54%) 43 (60%)   
It may be offered in some circumstances but the Italian code of 
Medical Ethics allows refusal due to conscientious objection 
12 (25%) 19 (26%)   
It may be offered in some circumstances but Italian legislation 
regulating voluntary abortion allows refusal due to conscientious 
objection 
10 (21%) 10 (14%) 0.604 
Total of responders 48 (100%) 72 (100%)   
Has it ever happened that one or more women arrived for care at the Emergency Department where you work and asked for 
a LNG-EC pill because they had been refused at another medical facility? 
Yes 13 (30%) 48 (66%) 0.001 
No 31 (70%) 25 (34%)   
Total of respondents 44 (100%) 73 (100%)   
*The expected answer is indicated in bold. 
**The sum of the reported percentages may not amount to 100% because of the rounding off. 
LNG-EC pills, levonorgestrel-only EC pills. 
 Table 4 Physician's knowledge about the levonorgestrel-only (LNG-EC) pill's pharmacokinetics 
Physician's knowledge about 
the LNG-EC pill's 
pharmacokinetics* 
Gynaecologists 
(n = 53) 
Emergency 








In which of the following circumstances do you believe providing a LNG-EC pill is indicated? 
Unprotected sexual intercourse in the 
120 hours preceding the request 
1 (2%) 5 (7%) 0.290 0.268 
Unprotected sexual intercourse during 
the fertile period 
2 (5%) 7 (9%)     
Unprotected sexual intercourse with 
subsequent risk of pregnancy 
8 (18%) 15 (20%)     
Rape 2 (5%) 1 (1%)     
All of the above 29 (66%) 42 (56%)     
None of the above 2 (5%) 5 (7%)     
Total of respondents 44 (100%)*** 75 (100%)     
Within how many hours after intercourse should a LNG-EC pill be prescribed? 
12–24 7 (14%) 7 (9%) 0.864 0.056 
48 2 (4%) 18 (24%)     
72 34 (69%) 47 (63%)     
120 4 (8%) 3 (4%)     
I don't know 2 (4%) 0 (0%)     
Total of respondents 49 (100%)*** 75 (100%)     
*The expected answer is indicated in bold. 
**Adjusted for gender, age, ED level, geographic location of the ED and requests for LNG-EC pills received (yes vs. no) in 
the previous year. 










Table 5 Physician's knowledge about the levonorgestrel-only (LNG-EC) pill's pharmacodynamics 
Physician's knowledge about the 
LNG-EC pill's pharmacodynamics* 
Gynaecologists 










Which is the more correct way of taking a LNG-EC pill? 
The first pill must be taken at prescription and 
the second 12 hours later 
15 (29%) 10 (13%) 0.003 0.138 
Both pills should be taken concurrently at 
prescription 
13 (26%) 39 (52%)     
Both of the above 14 (28%) 25 (33%)     
I don't know 9 (18%) 1 (1%)     
Total of respondents 51 (100%)*** 75 (100%)***     
Does a LNG-EC pill cause major side effects?   
Usually not, but it can cause nausea, vomiting 
and headache in some cases 
44 (94%) 72 (96%) 0.554 0.524 
Yes, severe metrorrhagia 2 (4%) 2 (3%)     
Yes, fetal malformations if contraception 
ineffective 
1 (2%) 0 (0%)     
Yes, other effects 0 (0%) 1 (1%)     
Total of respondents 47 (100%) 75 (100%)     
Is it necessary to do laboratory examinations before prescribing a LNG-EC pill? 
No 37 (77%) 60 (81%) 0.593 0.371 
Yes, blood coagulation tests 4 (9%) 2 (3%)     
Yes, a pregnancy test 6 (13%) 12 (16%)     
Yes, for other reasons 1 (2%) 0 (0%)     
Total of respondents 48 (100%)*** 74 (100%)     
What is the mechanism of action of a LNG-EC pill? 
It inhibits or delays ovulation 2 (4%) 13 (18%) 0.021 0.160 
It acts through a complex mechanism of action 
involving inhibition of ovulation and 
fertilisation, alteration of tubal ciliary motility 
and sperm motility, inhibition of implantation 
of embryo 
41 (84%) 53 (75%)   
It acts through an abortive mechanism like that 
of mifepristone 
6 (12%) 5 (7%)   
Total of respondents 49 (100%) 71 (100%)   
*The expected answer is indicated in bold.  
**Adjusted for gender, age, ED level, geographic location of the ED and requests for LNG-EC pills received (yes vs. no) in 
the previous year. 
***The sum of the reported percentages may not amount to 100% because of the rounding off. 
